Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Diabetic foot ulcers (DFUs) represent a significant complication affecting the lower extremities in individuals with diabetes. The development and progression of DFUs are primarily influenced by diabetic neuropathy (DN) and diabetic peripheral artery disease (DPAD). Recent studies indicate a novel link between the gut microbiota and these risk factors. However, it remains unclear whether a causal relationship exists between them. We obtained data on gut microbiota, derived from publicly available genome-wide association studies. Additionally, we included data on DN, diabetic polyneuropathy (DPN), and DPAD from the FinnGen consortium, considering these conditions as primary risk factors for the onset of DFUs. We employed the inverse variance weighting method for the primary effect analysis and conducted 3 sensitivity tests to ensure the robustness of the results. Our analysis revealed that 7 genera are associated with DN, 8 are associated with DPN, and 12 are associated with DPAD. Notably, the Lachnospiraceae emerged as a common risk factor for both DN [OR = 1.392, 95% CI (1.031, 1.880), P = .031] and DPAD [OR = 1.152, 95% CI (1.019, 1.303), P = .024]. Conversely, the Acidaminococcaceae was identified as a shared protective factor against both DPN [OR = 0.620, 95% CI (0.460, 0.837), P = .002] and DPAD [OR = 0.814, 95% CI (0.691, 0.959), P = .014]. The sensitivity analysis indicated minimal evidence of bias in this study. Our research findings suggest a potential causal relationship between gut microbiota and the key risk factors for developing DFUs. This suggests that early detection and prevention of this serious diabetic complication might be achievable through gut microbiota modulation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12384795PMC
http://dx.doi.org/10.1097/MD.0000000000043637DOI Listing

Publication Analysis

Top Keywords

gut microbiota
20
risk factors
16
artery disease
8
diabetic foot
8
foot ulcers
8
causal relationship
8
diabetic
7
gut
5
risk
5
dpad
5

Similar Publications

Microbiome dysbiosis in reflux esophagitis has been extensively studied. However, limited research has examined microbiota across different segments of the upper gastrointestinal tract in reflux esophagitis. In this study, we investigated microbial alterations in three esophageal segments (upper, middle, and lower) and the gastric fundus of reflux esophagitis patients and healthy controls.

View Article and Find Full Text PDF

Background: Improving the efficacy of anti-programmed death 1 (PD-1) monoclonal antibody (mAb) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy efficacy.

Methods: ELISA was used to compare the serum 5-hydroxyindoleacetic acid (5-HIAA) level in patients with NSCLC.

View Article and Find Full Text PDF

Introduction: Combined vascular endothelial growth factor/programmed death-ligand 1 blockade through atezolizumab/bevacizumab (A/B) is the current standard of care in advanced hepatocellular carcinoma (HCC). A/B substantially improved objective response rates compared with tyrosine kinase inhibitor sorafenib; however, a majority of patients will still not respond to A/B. Strong scientific rationale and emerging clinical data suggest that faecal microbiota transfer (FMT) may improve antitumour immune response on PD-(L)1 blockade.

View Article and Find Full Text PDF

Sepsis is a systemic inflammatory response syndrome triggered by infection. Severe sepsis is associated with dysbiosis of the intestinal flora and impaired intestinal function. Ellagic acid (EA) is a natural compound known for its ability to inhibit bacteria and viruses, thereby preventing infections.

View Article and Find Full Text PDF